You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,946,010


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,946,010 protect, and when does it expire?

Patent 10,946,010 protects ZUBSOLV and is included in one NDA.

This patent has forty-nine patent family members in thirty-one countries.

Summary for Patent: 10,946,010
Title:Abuse-resistant pharmaceutical composition for the treatment of opioid dependence
Abstract: There is provided pharmaceutical compositions for the treatment of e.g. opioid dependency comprising microparticles of a pharmacologically-effective amount of buprenorphine, or a pharmaceutically-acceptable salt thereof, in associative admixture with particles comprising a weak acid, or particles comprising weakly-acidic buffer forming materials. The composition may further comprise a disintegrant and/or particles of a pharmacologically-effective amount of naloxone, or a pharmaceutically-acceptable salt thereof. The compositions are useful in the treatment of opioid dependency/addiction and/or pain.
Inventor(s): Fischer; Andreas (Uppsala, SE)
Assignee: OREXO AB (Uppsala, SE)
Application Number:17/009,702
Patent Claim Types:
see list of patent claims
Composition; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 10,946,010: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, researchers, and businesses to navigate the complex landscape of intellectual property. This article will delve into the details of United States Patent 10,946,010, focusing on its claims, scope, and the broader patent landscape.

Overview of the Patent

United States Patent 10,946,010, titled "Abuse-resistant Pharmaceutical Composition for the Treatment of Opioid Dependency/Addiction and/or Pain," addresses a critical area in pharmaceuticals. The patent describes compositions designed to mitigate the abuse potential of opioid medications, a pressing issue given the current opioid crisis.

Claims of the Patent

Independent Claims

The patent includes several independent claims that define the core inventions. These claims typically outline the essential features of the invention that distinguish it from prior art. For example, Claim 1 might describe the composition of the abuse-resistant pharmaceutical, including the specific ingredients and their proportions[5].

Dependent Claims

Dependent claims build upon the independent claims, adding additional features or limitations. These claims help to further define the scope of the invention and can provide additional protection by covering various aspects of the invention[5].

Scope of the Patent

Patent Scope Metrics

The scope of a patent can be measured using metrics such as independent claim length and independent claim count. Research has shown that narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

Broadness and Specificity

The patent's scope is determined by the breadth and specificity of its claims. Broader claims may cover a wider range of applications but are more likely to face challenges during the examination process. In contrast, narrower claims are more specific and may have a higher likelihood of being granted but offer less extensive protection[3].

Examination Process

Impact on Patent Scope

The examination process can significantly affect the scope of patent claims. Studies have shown that the examination process tends to narrow the scope of patent claims, both in terms of claim length and claim count. This narrowing is more pronounced when the duration of the examination is longer[3].

Prior Art and Citation Data

Common Citation Document (CCD)

To understand the prior art related to this patent, tools like the Common Citation Document (CCD) are invaluable. The CCD consolidates citation data from participating IP offices, providing a single point of access to prior art cited by multiple offices. This helps in visualizing the search results for the same invention produced by several offices on a single page[1].

International Patent Landscape

Global Dossier

The Global Dossier service allows users to access the file histories of related applications from participating IP offices. This includes the IP5 Offices, which can provide insights into the global patent family for a specific application, including classification, citation data, and office actions[1].

Searchable Databases

Searching international patent databases, such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO), is essential to ensure that the invention is novel and non-obvious on a global scale[1].

Practical Considerations

Patent Assignment and Ownership

Understanding who owns the patent and any changes in ownership is crucial. The Patent Assignment Search tool provided by the USPTO allows users to search for patent assignments and changes in ownership, ensuring clarity on the current ownership status[1].

Patent Public Search

The Patent Public Search tool is a powerful resource for conducting preliminary patent searches. It offers enhanced access to prior art and modern interfaces, improving the overall patent searching process[1].

Regulatory and Legal Aspects

Small Claims Patent Court

The concept of a small claims patent court has been explored to address the high costs associated with patent litigation. Studies by the Administrative Conference of the United States (ACUS) have considered the feasibility and structure of such a court, which could impact how patent disputes related to this invention are resolved[2].

Key Takeaways

  • Claims Analysis: Understanding the independent and dependent claims is crucial for defining the scope of the patent.
  • Examination Process: The examination process can narrow the scope of patent claims, affecting their breadth and specificity.
  • Prior Art: Tools like the CCD and Global Dossier are essential for analyzing prior art and global patent families.
  • International Landscape: Searching international patent databases ensures the invention's novelty and non-obviousness globally.
  • Regulatory Considerations: Changes in legal and regulatory frameworks, such as the potential for a small claims patent court, can impact patent litigation.

FAQs

Q: What is the primary focus of United States Patent 10,946,010?

A: The primary focus of this patent is on abuse-resistant pharmaceutical compositions for the treatment of opioid dependency/addiction and/or pain.

Q: How can the scope of a patent be measured?

A: The scope of a patent can be measured using metrics such as independent claim length and independent claim count.

Q: What is the Common Citation Document (CCD), and how is it useful?

A: The CCD consolidates citation data from participating IP offices, providing a single point of access to prior art cited by multiple offices.

Q: Why is it important to search international patent databases?

A: Searching international patent databases ensures that the invention is novel and non-obvious on a global scale.

Q: How does the examination process affect patent claims?

A: The examination process tends to narrow the scope of patent claims, both in terms of claim length and claim count, especially when the duration of the examination is longer.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. ACUS - U.S. Patent Small Claims Court: https://www.acus.gov/research-projects/us-patent-small-claims-court
  3. SSRN - Patent Claims and Patent Scope: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. Cision - Orexo Interim Report Q2 2021: https://mb.cision.com/Main/694/3385238/1445092.pdf
  5. Unified Patents - US-10946010-B2: https://portal.unifiedpatents.com/patents/patent/US-10946010-B2

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,946,010

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Orexo Us Inc ZUBSOLV buprenorphine hydrochloride; naloxone hydrochloride TABLET;SUBLINGUAL 204242-006 Oct 4, 2016 RX Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Orexo Us Inc ZUBSOLV buprenorphine hydrochloride; naloxone hydrochloride TABLET;SUBLINGUAL 204242-001 Jul 3, 2013 RX Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Orexo Us Inc ZUBSOLV buprenorphine hydrochloride; naloxone hydrochloride TABLET;SUBLINGUAL 204242-005 Jun 4, 2015 RX Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Orexo Us Inc ZUBSOLV buprenorphine hydrochloride; naloxone hydrochloride TABLET;SUBLINGUAL 204242-002 Jul 3, 2013 RX Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.